Clinical Trial Update: A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for LJPC-501 in pediatric patients with hypotension related to distributive or vasodilatory shock, including catecholamine-resis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catecholamine-resistant Hypotension
• Distributive Shock
• Septic Shock

Drugs mentioned

• LJPC-501

Snippet

Sponsor: La Jolla Pharmaceutical Company | Conditions: Catecholamine-resistant Hypotension (CRH), Distributive Shock | Phase 2 | Status: UNKNOWN